At a glance
- Company
- Lunit
- Ticker
- KRX: 328130.KQ
- Announcement
- Partnership
- Location
- Seoul, South Korea
Key figures
- Framework agreement term
- five-year
- Starvision locations
- 79
- German federal states
- seven
- Annual breast cancer screenings and diagnoses supported across two institutions
- approximately 120,000
- Die Radiologie medical sites
- over 20
People
- Uwe PfeiferCEO of Starvision Service GmbH
- Brandon SuhCEO of Lunit
Products and programs
The five-year framework agreement covers the phased rollout of Lunit’s AI suite, including chest X-ray, mammography, tomosynthesis, and fracture detection, across 79 Starvision sites
SEOUL, South Korea, May 8, 2025 -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced a strategic partnership with Starvision Service GmbH, Germany’s largest private radiology network. Through a newly signed framework agreement, Lunit’s AI imaging solutions will be deployed across Starvision’s expansive network of radiological practices.
Starvision operates 79 locations across seven German federal states, delivering services in radiology, nuclear medicine, and radiation therapy. As a recognized leader in the DACH healthcare market, Starvision is known for its commitment to digital transformation, operational excellence, and high-quality patient care.
Under the agreement, Starvision will adopt several of Lunit’s AI solutions, including:
- Lunit INSIGHT CXR: AI-based chest X-ray analysis
- Lunit INSIGHT MMG: Mammography analysis solution
- Lunit INSIGHT DBT: Digital breast tomosynthesis interpretation
- RBfracture: AI-driven fracture detection
The first commercial deployments are already underway—including use of Lunit INSIGHT MMG at Radiologische Allianz in Hamburg, supporting the Hamburg breast cancer screening program under the Starvision network. Together with deployments at Die Radiologie, a major regional hospital group operating over 20 medical sites across Bavaria, Lunit’s solutions are now supporting approximately 120,000 breast cancer screenings and diagnoses annually across the two institutions.
The five-year framework agreement allows additional Starvision locations—and newly affiliated practices—to join at any time, enabling broad scalability across the network. New deployments and clinical trials are already in progress, with individual agreements being signed across Starvision’s entities as part of a phased implementation plan. Beyond Starvision, several other healthcare providers across Germany have also expressed interest, reflecting the expanding demand for AI-driven imaging solutions.
“Lunit’s AI solutions support our radiologists in delivering fast and accurate diagnoses. This strengthens diagnostic confidence and gives us more time to focus on what truly matters: the individual care of our patients,” said Uwe Pfeifer, CEO of Starvision Service GmbH.
“Partnering with Starvision accelerates our vision of bringing AI-powered precision diagnostics into everyday clinical practice," said Brandon Suh, CEO of Lunit. "Together, we are advancing a new era of radiology where technology enhances the expertise of physicians, delivering better outcomes for millions of patients in Germany and beyond.”
The partnership supports both companies’ vision of transforming healthcare through intelligent technology and setting new standards in radiology.
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.
In brief
Lunit says it has signed a five-year framework agreement with Starvision Service GmbH to introduce its AI imaging tools across the German radiology network’s 79 locations in seven federal states. The planned suite covers chest X-ray, mammography, digital breast tomosynthesis and fracture detection. Initial deployments are underway, including mammography analysis at Radiologische Allianz in Hamburg. Lunit says its solutions, including deployments at Die Radiologie in Bavaria, support approximately 120,000 breast cancer screenings and diagnoses each year across the two institutions. The agreement allows other Starvision practices to join over time, with further deployments and clinical trials in progress. Starvision CEO Uwe Pfeifer said the technology supports radiologists’ work and patient care; Lunit CEO Brandon Suh described the partnership as part of the company’s effort to expand clinical use of AI diagnostics.
Key takeaways
- Lunit and Starvision signed a five-year framework agreement covering phased deployment across 79 sites.
- The planned AI tools include chest X-ray, mammography, tomosynthesis and fracture detection.
- Lunit says deployments at two institutions support about 120,000 breast cancer screenings and diagnoses annually.
- Further deployments and clinical trials are underway across Starvision entities.
Earlier from Lunit
- Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening
- Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research
- Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca
- Lunit Secures Multi-Year Contract with UAE's Largest Healthcare Network to Power National AI Breast Cancer Screening Program
- World’s First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection